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a b s t r a c t 
This article presents datasets associated with the research ar- 
ticle entitled “Intravitreal gene therapy protects against reti- 
nal dysfunction and degeneration in sheep with CLN5 Bat- 
ten disease” (Murray et al., [1] ). The neuronal ceroid lipo- 
fuscinoses (NCL; Batten disease) are a group of fatal inher- 
ited diseases caused by mutations in a number of CLN genes 
that lead to degenerative and fatal encephalopathies in chil- 
dren. Naturally-occuring sheep models of NCL exist. Affected 
sheep share the clinical and pathological features of the hu- 
man disease, including retinal degeneration. Electroretinog- 
raphy (ERG) was employed to characterise the physiological 
changes in the degenerating retina of CLN5 and CLN6 forms 
of ovine NCL. ERGs were performed every two months from 
3 to 17 months of age in 11 NCL affected (6 CLN5 −/ − and 
5 CLN6 −/ −) sheep and 12 clinically normal heterozygous 
controls (6 CLN5 + / − and 6 CLN6 + / −) under three differ- 
ent adaptation conditions. A-wave and b-wave amplitudes 
were collected from each eye using the Eickemeyer Veteri- 
nary ERG system. These are the first longitudinal datasets 
assessing the progression of retinal degeneration in ovine 
NCL, aiding in characterisation of the disease process and 
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providing insight into optimal therapeutic windows for sub- 
sequent studies. 
© 2021 The Authors. Published by Elsevier Inc. 
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b  pecifications Table 
Subject Ophthalmology and Neuroscience 
Specific subject area Retinal physiology 
Neurodegeneration 
Type of data Graph 
Figure 
How data were acquired A-wave and B-wave ERG amplitudes were collected using the 
Eickemeyer Veterinary ERG system (Eickemeyer - Medizintechnik für 
Tierärzte KG, Tuttlingen, Germany). 
Data format Raw 
Analyzed 
Parameters for data collection Longitudinal ERG recordings were collected from 23 sheep, including 
11 NCL affected (6 CLN5 −/ − and 5 CLN6 −/ −) and 12 clinically normal 
heterozygous controls (6 CLN5 + / − and 6 CLN6 + / −) between 3 and 17 
months of age. 
Description of data collection Sheep were anaesthetized and their pupils were dilated. ERG 
recordings were collected initially under ambient light (light 
adaptation). The light was then turned off and a (zero minute) dark 
adaptation recording was performed immediately. After five minutes 
dark adaptation a third recording was performed. 
Data source location Institution: Lincoln University 
City/Town/Region: Lincoln, Canterbury 
Country: New Zealand 
Data accessibility Repository name: Data in Brief (DIB) DataVerse 
https://doi.org/10.7910/DVN/JOSWTD 
Related research article Murray, S.J., Russell, K.N., Melzer, T.R., Gray, S.J., Heap, S.J., Palmer, D.N., 
Mitchell, N.L., 2021. Intravitreal gene therapy protects against retinal 
dysfunction and degeneration in sheep with CLN5 Batten disease. Exp. 
Eye Res. 207, 108600. https://doi.org/10.1016/j.exer.2021.108600 
alue of the Data 
• These longitudinal datasets provide the first electroretinographic (ERG) characterisation of
retinal degeneration in two ovine models of neuronal ceroid lipofuscinoses. 
• The ERG datasets can be used for the study of normal retinal function in sheep as
well as the assessment of therapeutic efficacy of ocular gene therapies in NCL sheep
models. 
• These datasets can be used to determine the optimal therapeutic window for ocular therapies
for ovine NCL. The data can be reused to perform regression analyses to determine the rate
of decline of ERG amplitudes in clinically normal and NCL affected sheep and to compare
this to rates of decline in animals who have received an ocular treatment. 
. Data Description 
Two full datasets have been deposited on a repository [ 2 ]. Each file consists of a
icrosoft Excel Spreadsheet, containing six worksheets for the longitudinal a-wave and
-wave ERG amplitudes for each of the three light adaptation conditions (light-adapted, zero



































minutes dark-adapted, and 5 minutes dark-adapted) respectively. The first spreadsheet, entitled
CLN5 Full Dataset, has longitudinal ERG recordings from 6 CLN5 affected ( CLN5 −/ −) and 6 clin-
ically normal CLN6 heterozygous ( CLN5 + / −) sheep. The second spreadsheet, entitled CLN6 Full
Dataset, has longitudinal ERG recordings from 5 CLN6 affected ( CLN6 −/ −) and 6 clinically normal
CLN6 heterozygous ( CLN6 + / −) sheep. For each animal in these datasets, the ERG recording for
the left and right eye are shown, as well as the average for both eyes. 
Four tagged image file format (tif) files are provided with this article. Two of these show
graphs of the mean longitudinal a-wave and b-wave ERG amplitudes for each of the three
light adaptation conditions for CLN5 and CLN6 sheep respectively ( Graph 1 CLN5 ERG and
Graph 2 CLN6 ERG). The other two tif files contain representative individual ERG traces from
CLN5 and CLN6 sheep respectively at different ages under the three different lighting situations
( Fig. 1 CLN5 Traces and Fig. 2 CLN6 Traces). 
2. Experimental Design, Materials and Methods 
2.1. Animals 
This longitudinal investigation included a total of 23 sheep: 12 animals born in 2014 and
11 born in 2015. The first cohort of 12 (6 affected males, 6 female controls) were not enrolled
until after 11 months of age whereas the second cohort of 11 (5 affected f emales, 6 f emale
controls) were studied from 3 months of age. Each cohort contained CLN6 −/ − ( n = 2-3) and
CLN6 + / − ( n = 3) South Hampshire sheep and CLN5 −/ − ( n = 3) and CLN5 + / − ( n = 3) Borderdale
sheep. The heterozygous sheep (i.e. CLN5 + / − and CLN6 + / −) were clinically normal and served as
control animals. Sheep were maintained on outdoor pasture. 
Prior to testing, the sheep were brought indoors, fasted for 18-24 h and weighed. 1% Tropi-
camide (Mydriacyl, 10 mg/mL; Alcon NZ Ltd, Auckland, NZ) was administered to achieve my-
driasis during recordings. Sheep were anaesthetised by intravenous injection of 0.5 mg/kg live
weight (LW) diazepam (Pamlin injection, Troy Laboratories NZ Pty Ltd, Auckland, NZ) and
10 mg/kg LW of ketamine hydrochloride (Phoenix Ketamine injection, Phoenix Pharm Distribu-
tors Ltd, Auckland, NZ). After intubation, they were maintained on inhalation anaesthesia, isoflu-
rane in oxygen (1.5% - 3% v/v to effect). 
2.2. Electroretinography (ERG) 
Electroretinography was conducted using an Eickemeyer Veterinary ERG system (Eickemeyer 
- Medizintechnik für Tierärzte KG, Tuttlingen, Germany). The eye was kept open with a 40 mm
Barraquer speculum, whilst a gold-plated ERG-Jet contact lens electrode (Fabrinal SA, La Chaux-
De-Fonds, Switzerland), filled with sterile saline solution, was placed on the eye. Subdermal
12 mm, 29-gauge needle electrodes (LKC Technologies Inc., Gaithersburg, MD, USA) were placed
approximately 1 cm lateral to the lateral canthus (reference), and onto the dorsal surface of
the skull (earth) 1 cm lateral to the midline towards the eye that was being measured. The
light stimulus was positioned within 1 cm of the eye and delivered four consecutive flashes of
white light (2-3 cd/m 2 ) at an interval of 0.8 seconds. The first recording was performed with the
ambient light turned on (light adaptation). The light was then turned off and a second record-
ing (zero minutes dark adaptation) was performed immediately. Finally, following five minutes
in the dark, the third recording (five minutes dark adaptation) was performed. A minimum of
10 minutes was allowed between eye recordings to allow the contralateral eye to become light












































Fig. 1. Individual longitudinal electroretinography (ERG) traces from CLN5 animals. Representative individual ERG traces from CLN5 affected (CLN5-/-) and clinically normal heterozy- 
gous control (CLN5 + /-) sheep at different ages in different lighting situations. (A) ERGs obtained in ambient lighting, (B) ERGs obtained immediately after light was turned off, (C) ERGs 












































Graph 1. Mean amplitudes of electroretinography (ERG) a- and b-waves in CLN5 sheep. 
Mean amplitudes ( ± SEM) from clinically normal heterozygous control (CLN5 + /-) and CLN5 affected (CLN5-/-) sheep at different ages. Left column shows a-waves, right column shows 
b-waves. Light adapted ERGs were obtained first (A, B), followed by a measurement immediately after the light was turned off (C, D), and a third measurement after five minutes of dark 
adaptation (E, F). ∗ indicates where P < 0.05 after a mixed effects model followed by Tukey’s multiple comparisons test. 
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Fig. 2. Individual longitudinal electroretinography (ERG) traces from CLN6 animals. Representative individual ERG 
traces from CLN6 affected (CLN6-/-) and clinically normal heterozygous control (CLN6 + /-) sheep at different ages in 
different lighting situations. (A) ERGs obtained in ambient lighting, (B) ERGs obtained immediately after light was turned 

















.3. Data processing and statistical analysis 
ERG a- and b-wave amplitudes were determined for each eye for each type of adaptation at
ach age using the provided software (Eickemeyer). The a-wave amplitude was calculated as the
istance from the centre line (or still position) to the trough of the a-wave whilst the b-wave
mplitude was calculated from the trough of the a-wave to the peak of the b-wave. Average
easures were then calculated from both eyes. Both raw and average data for each animal are
resented in the datasets. 
All statistical analyses were performed on GraphPad Prism (v 8.2.0, GraphPad Software 
Animals were grouped by breed and genotype ( CLN5 + / −, CLN5 −/ −, CLN6 + / − and CLN6 −/ −)
nd the repeated measurements were allocated into age-groups (3, 5, 7, 9, 11, 13, 15 and
7 months). Means and corresponding standard error of the mean (SEM) values were calcu-
ated for each genotype for each measurement for each age. A mixed-effects model, fit using
estricted Maximum Likelihood (REML), followed by Tukey’s multiple comparisons test was per-
ormed using GraphPad Prism version 8.2.0 for Windows (GraphPad Software, San Diego, CA,
SA, www.graphpad.com ) for each set of measurements to investigate the effects of time and
isease status on the a- and b-wave amplitudes. Differences were regarded significant where < 0.05. 
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Graph 2. Mean amplitudes of electroretinography (ERG) a- and b-waves in CLN6 sheep. 
Mean amplitudes ( ± SEM) of clinically normal heterozygous control (CLN6 + /-) and CLN6 affected (CLN6-/-) sheep at 
different ages. Left column shows a-waves, right column shows b-waves. Light adapted ERGs were obtained first (A, 
B), followed by a measurement immediately after the light was turned off (C, D), and a third measurement after five 
minutes of dark adaptation (E, F). ∗ indicates where P < 0.05 after a mixed effects model followed by Tukey’s multiple 
comparisons test. 
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